<DOC>
	<DOCNO>NCT02471209</DOCNO>
	<brief_summary>To evaluate effect sevoflurane hepatic blood flow ( HBF ) hepatic arterial buffer response ( HABR ) infant obstructive jaundice Doppler ultrasound.Twenty-five infant biliary atresia ( 1-3 months-of-age ) schedule Kasai procedure enrol . portal vein blood flow ( PBF ) , hepatic arterial blood flow ( HABF ) hepatic blood flow ( HBF ) measure Doppler ultrasound induction , inhalation 2 3 % sevoflurane .</brief_summary>
	<brief_title>Biliary Atresia , Hepatic Buffer Response Sevoflurane</brief_title>
	<detailed_description>Children suffer hepatobiliary disease also hepatic arterial buffer response ( HABR ) reduce portal vein blood flow ( PBF ) compensatory increase hepatic arterial blood flow ( HABF ) help maintain hepatic blood flow ( HBF ) . For infant obstructive hepatobiliary disease , reduce HBF may affect drug metabolism increase risk respiratory depression analgesia , life-threatening . To evaluate effect sevoflurane HBF HABR infant obstructive jaundice Doppler ultrasound.Twenty-five infant biliary atresia ( 1-3 months-of-age ) schedule Kasai procedure enrol . PBF , HABF HBF measure Doppler ultrasound induction , inhalation 2 3 % sevoflurane .</detailed_description>
	<mesh_term>Biliary Atresia</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>persistent yellow skin sclera , pale stool ( severe case , claylike ) , hepatomegaly ; increase serum bilirubin ( progressively decline increase ) , increase total bilirubin ( TBil ) dominate increased direct bilirubin ( DBil ) ( &gt; 60 % ) ; elevate liver enzyme ; ultrasound confirmation poor gallbladder fill sign liver fibrosis ; radionuclide image confirmation obstruct biliary excretion concomitant cardiovascular abdominal organ malformation</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>